Abstract:The outbreak and spread of coronavirus disease 2019 (COVID-19) highlighted the impor-tance and urgency of the research and development of therapeutic drugs. Very early into the COVID-19 pandemic, China has begun developing drugs, with some notable progress. Herein, we summarizes the anti-COVID-19 drugs and promising drug candidates originally developed and researched in China. Furthermore, we discussed the developmental prospects, mechanisms of action, and advantages and dis-advantages of the anti-COVID-19 drugs in development, with the aim to contribute to the rational use of drugs in COVID-19 treatment and more effective development of new drugs against severe acute respi-ratory syndrome coronavirus 2 (SARS-CoV-2) and the variants. Neutralizing antibody is an effective approach to overcome COVID-19. However, drug resistance induced by rapid virus mutation will likely to challenge neutralizing antibodies. Taking into account current epidemic trends, small molecule drugs have a crucial role in fighting COVID-19 due to their significant advantage of convenient administration and affordable and broad-spectrum. Traditional Chinese medicines, including natural products and tradi-tional Chinese medicine prescriptions, contribute to the treatment of COVID-19 due to their unique mechanism of action. Currently, the research and development of Chinese anti-COVID-19 drugs have led to some promising achievements, thus prompting us to expect even more rapidly available solutions.(c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Research Progress on Small-Molecule Drugs for Treating COVID-19

Small molecules in the treatment of COVID-19

Recent advances in developing small-molecule inhibitors against SARS-CoV-2

Therapeutic strategies for COVID-19: progress and lessons learned

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules

Current state-of-the-art and potential future therapeutic drugs against COVID-19

An update review of emerging small-molecule therapeutic options for COVID-19

Progress on COVID-19 Chemotherapeutics Discovery and Novel Technology

COVID-19 drug discovery and treatment options

Update: Drug Treatment Options for Coronavirus Disease 2019 (COVID-19).

Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply

Insights into Biological Therapeutic Strategies for COVID-19

Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

Research and development of Chinese anti-COVID-19 drugs

Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development

Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

Identification and Development of Therapeutics for COVID-19